Results 151 to 160 of about 4,347,639 (355)

Defeating Multidrug‐Resistant ESKAPEE Pathogens With Polymer Nanomaterials

open access: yesAdvanced Science, EarlyView.
Antimicrobial resistance, particularly among ESKAPEE pathogens, represents a major global health threat and drives the need for innovative treatments. Polymer‐based strategies offer promising alternatives to conventional antibiotics by overcoming resistance mechanisms.
Thu Ba Tô   +4 more
wiley   +1 more source

Cancer Trends: Cancer of the pancreas

open access: yes, 2012
Cancer of the pancreas accounts for approximately 2.5% of all invasive cancers and is the 9th most commonly diagnosed cancer in Ireland.1 Almost 400 cases of pancreatic cancer were diagnosed annually between 1994 and 2010 (Table 1).
National Cancer Registry Ireland (NCRI)
core  

Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines

open access: yes
Human papillomavirus (HPV) is a major global health issue and is recognized as the leading cause of cervical cancer. While prophylactic vaccination programs have led to substantial reductions in both HPV infection rates and cervical cancer incidence ...
Ling Long   +7 more
core   +1 more source

WDR76 Drives Hepatocellular Carcinoma Stemness and Progression by Stabilizing CBX5 and Promoting Phase Separation‐Dependent Chromatin Remodeling

open access: yesAdvanced Science, EarlyView.
Upregulated WDR76 recruits USP14 to stabilize CBX5, promoting nuclear liquid‐liquid phase separation and DNA co‐condensation. This drives heterochromatin‐associated chromatin remodeling and stemness‐related transcriptional programs, thereby enhancing HCC stemness, tumor progression, and reduced lenvatinib sensitivity.
Jingduo Deng   +21 more
wiley   +1 more source

Advances in Cancer Vaccines for Digestive System Cancers: A Systematic Analysis of Clinical Trials [PDF]

open access: yes
Jianing Li,1 Peili Wang2 1Graduate School, Heilongjiang University of Chinese Medicine, Harbin, People’s Republic of China; 2Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of ChinaCorrespondence: Peili Wang, Email ...
Li J, Wang P
core  

Ligand‐Ratio–Tuned DNA Nanocarriers Overcome Bladder Barriers for Ultralow‐Dose Intravesical Therapy

open access: yesAdvanced Science, EarlyView.
A programmable DNA framework drug carrier coordinates barrier transport, tumor targeting, and drug delivery through ligand‐ratio engineering. Systematic exploration of the Sgc8/fluorocarbon design space reveals a nonlinear optimal balance between penetration and cellular engagement, translating multifunctional integration into durable bladder tumor ...
Dunfang Liu   +5 more
wiley   +1 more source

Spray‐Dried mRNA‐LNP Powder Enabling Multi‐Route Delivery With 3‐Year Refrigerated Stability

open access: yesAdvanced Science, EarlyView.
Spray‐dried mRNA‐LNP powder with trehalose matrix enables reconstitution for parenteral delivery or direct administration via pulmonary and sublingual routes, maintaining protein expression comparable to liquid controls. The thermostable powder preserves colloidal stability, mRNA integrity, and biological activity for over 3 years at 2°C–8°C, while ...
Ashish Sarode   +4 more
wiley   +1 more source

Harnessing Nanogold in Therapeutic Cancer Vaccines [PDF]

open access: hybrid
Joshua Seaberg   +2 more
openalex   +1 more source

Cancer Trends: Cancer of the liver and biliary tract

open access: yes, 2010
Liver cancer consists of two main types—hepatocellular carcinoma (HCC) which accounts for about 60% of cases, and intrahepatic bile duct cholangiocarcinoma (ICC), which accounts for about 20%. The liver is one of the less common cancer sites, about 0.
National Cancer Registry Ireland (NCRI)
core  

Tolerogenic Immunotherapy for Type 1 Diabetes Through Sustained Autoantigen Delivery in a Transient Inflammatory Niche

open access: yesAdvanced Science, EarlyView.
Sustained co‐delivery of insulin autoantigen and low‐dose interleukin‐2 from an injectable hydrogel depot established a transient tolerogenic niche that expanded regulatory T cells and delayed median diabetes onset from 20 to >40 weeks in non‐obese diabetic mice.
Leslee T. Nguyen   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy